MedTrace Logo

Patient Compliance With Long-Acting Reversible Contraception Administration

NCT03305081 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2021-01-22

Study results available
· View outcomes & findings →

Summary

This a randomized control trial to identify if patients who desire LARC are more likely to have success receiving the desired form of contraception if it is placed a) during the postpartum hospital stay, either in the immediate or early postpartum period, versus b) during the interval postpartum period as previously done.

Conditions

  • Contraception

Interventions

DEVICE

Levonorgestrel IUD, copper IUD, etonorgestrel implant

Long-acting reversible contraception

Sponsors & Collaborators

  • Tulane University School of Medicine

    lead OTHER

Principal Investigators

  • Sara Junya, MD · Tulane University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-22
Primary Completion
2015-12-21
Completion
2016-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03305081 on ClinicalTrials.gov